Abbott to Acquire Exact Sciences, a Leader in Large and Fast-Growing Cancer Screening and Precision Oncology Diagnostics Segments

Abbott will acquire Exact Sciences for about $21 billion, gaining a foothold in fast-growing cancer screening and precision oncology diagnostics. The deal values Exact at $105 per share and aims to ex…